Business news – Page 71
-
Business
Bristol-Myers Squibb to buy Cardioxyl for heart drug
Deal worth up to $2bn gives BMS full rights to Phase II clinical candidate
-
Business
Job cuts at Daiichi, Perrigo and Cabot
Staff reductions aimed at cutting costs or, in Perrigo’s case, fending off a takeover bid
-
News
Malaria vaccine pilot studies recommended by WHO
GlaxoSmithKline’s RTS,S vaccine must undergo further testing before being rolled out, says World Health Organization panel
-
Business
Biogen to cut 800 jobs worldwide
US biotech is reducing its workforce by 11% and cancelling several R&D programmes to cut costs
-
Business
Nine dead in China plant blast
Explosion in Shandong province latest of several incidents in Chinese chemical plants
-
Business
BMS agrees $1.7bn immuno-oncology collaboration
Deal strengthens cancer antibody alliance with Five Prime Therapeutics
-
Business
Raising industry’s voice
Canadian companies need to engage more with government to safeguard competitiveness while improving sustainability
-
Business
DuPont found liable for cancer case
US court orders firm to pay $1.6m in damages for disease linked to contaminated water supply
-
Business
Monsanto plans 2600 layoffs
Sales losses prompt agrochemical giant to slash workforce by 12% over the next two years
-
Business
EPA fines Mosaic Fertilizer over hazardous waste handling
US Environmental Protection Agency agrees settlement contract including $8m penalty and $800m in investments
-
Business
Controversial new trade deal finalised
The Trans-Pacific Partnership could raise the price of medicines, especially in developing nations
-
Business
Bristol-Myers Squibb fined for alleged Chinese bribes
US Securities and Exchange Commission accepts $14m settlement for charges covering the last five years
-
Business
Safety board fills in details of deadly DuPont leak
In interim investigation has outlined the events and safety failings leading to a methyl mercaptan release that killed four workers
-
Opinion
Human capital
Business leader: Incubators and hubs for small and medium-sized enterprises are all the fashion
-
Opinion
What the market will bear?
Martin Shkreli’s monopolising model poses some uncomfortable questions for the pharma industry, says Derek Lowe
-
Business
Drax pulls out of carbon capture power station plans
Energy giant says government policies have slashed income and made carbon capture project too costly
-
Opinion
Spice up your compounds
An occasional foray into uncharted territory is the hot sauce of medicinal chemistry, says Derek Lowe
-
Business
Bayer CropScience pays $5.6m to settle 2008 accident charges
Fine will fund environmental projects, fire department upgrades and wastewater treatment facilities
-
Business
Cosmetics deals push skin 3D bioprinting
Interest for testing from L’Oréal, BASF and Procter & Gamble could be a stepping stone towards bespoke organs